Various MHRA safety alerts

Three affected products

MHRA has issued various safety alerts:

Class 2: Veriton Pharma Limited, Epistatus 2.5 mg oromucosal solution, pre-filled syringe (Veriton Pharma Limited)

One affected batch is being recalled:

Batch Number	Expiry Date	Pack Size	First Distributed
230327A2	09/2024	1 x 0.25ml PFS	05/06/2023

Active Pharmaceutical Ingredient: Each pre-filled oral syringe contains 0.25ml of

The affected batch has the potential for some products to appear cloudy and/or contain crystalline particles.

Class 4 Medicines Defect Information: Kyowa Kirin Limited, Tostran (Testosterone, 2% gel)

In seven affected batches the priming instructions in the current PIL for Tostran 2% gel require updating to ensure an accurate first dose may be delivered. The Patient Information Leaflet and Summary Product Information will be updated.

Class 4 Medicines Defect Information: Galderma (U.K.) Limited, Loceryl 5% w/v Medicated Nail Lacquer (5.0 ml)

The following affected batch is licensed only for distribution in Ireland. Although Loceryl is a registered medicine in both Ireland and the UK, there are differences between these products in the product labelling and Patient Information Leaflet (PIL) packaged with the medicine.